- Posted Tuesday October 29, 2013
Nov. 3 event at Tempe Kiwanis Park benefits pancreatic cancer patients
TEMPE, Ariz. - Oct. 29, 2013 - The 8th annual
stepNout Run/Walk/Dash continues a march toward the $1 million mark
in fundraising for pancreatic cancer research at the Translational
Genomics Research Institute (TGen).
Registration begins at 7 a.m., opening ceremonies are set for 8:45 a.m., and races - including a 5K run - start at 9 a.m. on Nov. 3 at Tempe's Kiwanis Park, 6111 S. All-America Way. Nearly 1,000 participants are expected again this year.
Vowing to "fight pancreatic cancer, one step at a time," organizers have set a goal to eventually surpass the $1 million mark in fundraising. Participants in stepNout have donated more than $600,000 since the event started in 2006.
This year's stepNout emcee will be ABC15 News Emmy-award-winning journalist and cancer survivor Amy Murphy.
Also this year, stepNout will finish with a family carnival, including a zip-line.
Among the ways to raise funds, supporters can purchase $5 raffle tickets (5 for $20) for a chance to win a $1,000 VISA gift card. Raffle tickets are available at www.helptgen.org. Winner does not need to be present and will be notified by phone. Every dollar raised through this promotion brings us one step closer to a cure.
Participants also can join a team, sponsor a runner, or simply make a donation. Online registration ends today (Oct. 29). You may still register at the event, starting at 7 a.m.
One of TGen's goals is to develop a method of early detection for pancreatic cancer. Currently, there are no tests to catch this disease in its early stages. As a result, it is often not diagnosed until its late stages, making it difficult to treat. More than 45,000 Americans will be diagnosed with pancreatic cancer this year, and more than 38,000 will die from this disease, which kills 74 percent of those diagnosed within the first year. Only 6 percent survive more than five years. The pancreas is a gland behind the stomach that secretes enzymes into the small intestine to help digestion and produce hormones.
TGen Foundation President Michael Bassoff said that each year the stepNout event enables thousands of people to join TGen's fight against pancreatic cancer.
"Our research team's recent success can be traced to the thousands of patients and friends who participate in this event each year. We expect the largest event in our history and trust that the research team will use these funds to continue their incredible progress," Bassoff said.
November is national Pancreatic Cancer Awareness Month, a special time for TGen's National Pancreatic Cancer Committee as it marks 8 years of making a difference in the lives of those battling the nation's fourth leading cause of cancer death.
If you go to stepNout
What: The Translational Genomics Research Institute's (TGen's) 8th annual stepNout Run/Walk/Dash, benefiting TGen pancreatic cancer research.
Where: The south end of Tempe's Kiwanis Community Park, 6111 S. All-America Way, Tempe. Enter off Guadalupe Road at All American Way, between Rural and Kyrene roads.
When: 7-11 a.m. Sunday, Nov. 3. Registration starts at 7 a.m.; races begin at 9 a.m.; an awards ceremony is set for 10 a.m.; and a kids' dash is planned for 10:30 a.m.
Cost: Registration fees range from $15 to $35, depending on age and competition. Children ages 4 and under are free.
Registration: You can register at the event, or register online by Oct. 29 by visiting www.tgenfoundation.org and clicking the stepNout icon.
Parking: Parking is available along All-American Way and surrounding lots.
Why: Organizers hope to raise more than $100,000 for TGen pancreatic cancer research.
# # #
Translational Genomics Research Institute (TGen) is a Phoenix, Arizona-based non-profit organization dedicated to conducting groundbreaking research with life changing results. TGen is focused on helping patients with cancer, neurological disorders and diabetes, through cutting edge translational research (the process of rapidly moving research towards patient benefit). TGen physicians and scientists work to unravel the genetic components of both common and rare complex diseases in adults and children. Working with collaborators in the scientific and medical communities literally worldwide, TGen makes a substantial contribution to help our patients through efficiency and effectiveness of the translational process. For more information, visit:www.tgen.org.
Vice President of Development, Cancer Programs
TGen Senior Science Writer